Cytochrome P450 Inhibition to Decrease Dosage of Dasatinib for Chronic Myelogenous Leukemia

Clinical trial NCT05638763 · UNKNOWN

Trial details

NCT number: NCT05638763
Sponsor: Hospital Universitario Dr. Jose E. Gonzalez
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia, Chronic Phase

Start date: 2024-11-01
Primary completion: 2024-11-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.